| Market Capitalization (Millions $) |
1 |
| Shares
Outstanding (Millions) |
0 |
| Employees |
9 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-7 |
| Cash Flow (TTM) (Millions $) |
1 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Aethlon Medical Inc is a medical technology company that focuses on the development of therapeutic devices to address infectious diseases, cancer, and other life-threatening conditions. The company's flagship product is the Aethlon Hemopurifier, which is designed to remove certain targeted agents from the circulatory system. This device is currently being studied as a potential treatment for viral infections, including HIV and hepatitis C.
In addition to the Hemopurifier, Aethlon Medical is also engaged in the development of exosomes-based technology called the ESI platform, which is designed to diagnose and monitor the progression of cancer. The company has collaborations with various research institutes and healthcare organizations for the advancement of its products.
Aethlon Medical was founded in 1991 and is headquartered in San Diego, California. The company aims to provide innovative and effective treatments for life-threatening conditions through its therapeutic devices and technologies.
Company Address: 11555 Sorrento Valley Road San Diego 92121 CA
Company Phone Number: 941-0360 Stock Exchange / Ticker: NASDAQ AEMD
|
0.000%
